Degenerative osteoarthritis, also known as osteoarthritis, is one of the most common musculoskeletal conditions worldwide, affecting millions of people with chronic pain, stiffness, and loss of mobility in joints such as the knees, hips, and shoulders. At Stem Cell Therapy Argentina®, we specialize in regenerative therapies based on stem cells and biological derivatives, offering non-surgical alternatives that not only alleviate symptoms but also promote tissue regeneration. Unlike other clinics that may operate without rigorous controls, we strictly adhere to international biosafety standards, quality assurance, and regulations from ANMAT (National Administration of Drugs, Food and Medical Technology) in Argentina, ensuring reproducible results supported by global scientific consensus.
In this article, we will explore our three main treatments for degenerative osteoarthritis: Hyperconcentrated Platelet-Rich Plasma®, Micronized Adipose Tissue – Microfat® – and Expanded Mesenchymal Cells under the “AlliaCells®” protocol.
These protocols are not only supported by international clinical studies and meta-analyses, but are also distinguished by their focus on biosafety, with exhaustive controls in cell counting, the use of instruments authorized and approved by regulatory authorities, and quality based on Good Manufacturing Practices (GMP). While many clinics in the market fail to meet these standards, exposing patients to risks such as contamination or inconsistent results, at Stem Cell Therapy Argentina® we prioritize scientific excellence and safety to reproduce outcomes validated by organizations such as the World Health Organization and international orthopedic societies.
1. Hyperconcentrated Platelet-Rich Plasma®: Precision and effective biological anti-inflammatory
Our Hyperconcentrated PRP® is an exclusive protocol that uses platelet-rich plasma derived from the patient’s own blood, processed to achieve an optimal concentration of growth factors and platelets (more than 10 billion, according to optimized studies). This injectable treatment promotes inflammation reduction, pain relief, and improved joint function in patients with osteoarthritis. Scientific studies, such as meta-analyses published in journals like Nature and PMC, have demonstrated that Platelet-Rich Plasma offers clinically relevant improvements in pain and mobility at 3, 6, and 12 months post-treatment, with success rates of 60-70% in cases of knee osteoarthritis. These results align with international consensus from societies such as the American Academy of Orthopaedic Surgeons, which support PRP as a first-line therapy for moderate OA.
What sets our Hyperconcentrated PRP® apart is its rigorous approach to biosafety. We ensure complete sterility and prevent contamination. Precise platelet counting is performed using validated automated counters, guaranteeing a reproducible hyperconcentrated dose. Unlike other clinics that use in-house or unregulated methods, which can lead to variability in efficacy and infectious risks, we offer documented quality guarantees, with serological controls and complete traceability, faithfully replicating global clinical trial protocols to maximize safety and effectiveness.
2. Micronized Adipose Tissue – Microfat® -: from the patient’s own Fat Tissue.
Microfat® involves the extraction and micronization of autologous (from the patient’s own) adipose tissue under highly biosafety conditions, such as an operating room, under local anesthesia, without sedation. The tissue is then processed to obtain a suspension rich in vascular stromal cells and regenerative factors. This injectable treatment is ideal for advanced osteoarthritis, as it modulates joint inflammation, promotes cartilage repair, and improves function. Clinical research, including studies in PMCs and specialized journals, has demonstrated significant improvements in pain and function following injections of microfragmented adipose tissue, with sustained benefits in patients with knee osteoarthritis when combined with arthroscopic debridement. These findings are based on international consensus that highlights the regenerative potential of adipose tissue in osteoarthritis, differentiating it from less proven approaches.
At Stem Cell Therapy Argentina®, biosafety is paramount: processing is performed in GMP-compliant environments, using lipoaspirators and micronizers approved by ANMAT (the Argentine National Administration of Drugs, Food and Medical Technology). Viable cell counting is verified using LUNA® cell counters, the best on the market, ensuring purity and potency. While other clinics may use unauthorized equipment or even equipment intended for other purposes, risking impurities or adverse reactions, we guarantee sterility, traceability, and quality controls that comply with international regulations and standards. This allows us to reproduce results from global studies with high fidelity, offering patients a safe and effective therapy.
3. Expanded Mesenchymal Cells – AlliaCells® -: Innovation in Cell Expansion
The AlliaCells® protocol and procedure uses mesenchymal stem cells (MSCs) expanded in the laboratory from the patient’s own adipose tissue, which are injected to regenerate damaged cartilage and reduce inflammation in osteoarthritis. Multicenter clinical trials and systematic reviews have confirmed its efficacy in phase III studies, showing improvements in pain, function, and long-term quality of life, with intra-articular injections outperforming placebos in meta-analyses. These results are supported by consensus statements such as those from the International Society for Cellular Therapy, positioning expanded MSCs as a frontier treatment for OA.
Our commitment to biosafety elevates this treatment: cell expansion takes place in GMP-accredited laboratories, using technology and culture media authorized by ANMAT (Argentina’s National Administration of Drugs, Food and Medical Technology). Precise cell counting (viability >90%) is performed with validated equipment, and each batch undergoes sterility, endotoxin, and potency testing. Unlike unregulated centers that might offer “experimental” therapies without controls, exposing patients to risks such as immunogenicity or infections from bacteria in the cultures or through cross-contamination of samples, at Stem Cell Therapy Argentina® we comply with regulations for cell products, ensuring safety guarantees and replicating international clinical trial protocols for consistent results.
Why Choose Stem Cell Therapy Argentina®? The Difference in Standards and Results
In a market where many clinics offer regenerative therapies without adhering to Good Manufacturing Practices (GMP) or ANMAT regulations, Stem Cell Therapy Argentina® stands out for its unwavering commitment to biosafety and scientific evidence. Our instruments—from centrifuges and laminar flow hoods to BTL® technology, the Ebers® insole system, and cell counters like the LUNA F®—are approved and calibrated according to international standards, with traceability protocols that guarantee the purity and efficacy of each treatment. This not only minimizes risks but also allows us to replicate results from global consensus, such as those of the Osteoarthritis Research Society International, with superior and lasting success rates.
If you suffer from degenerative osteoarthritis, don’t settle for substandard options and pay as if they were high-quality. Contact Stem Cell Therapy Argentina® for a personalized evaluation and discover how our proven therapies can safely and scientifically transform your quality of life. Visit our website www.stemcelltherapyargentina.com or schedule a consultation today at +54 9 11 24704646.
